Last reviewed · How we verify

NCT04955535

Screening of Specific Genes for Pigmented Villous Nodular Synovitis

Completed Last updated 8 July 2021
What this trial tests

trial testing Arthroscopic synovectomy in Pigmented Villonodular Synovitis in 60 participants. Completed in 27 December 2020.

Timeline
3 August 2020
Primary endpoint
27 December 2020
27 December 2020

Quick facts

Lead sponsorPeking University Third Hospital
StatusCompleted
Study typeOBSERVATIONAL
Enrollment60
Start date3 August 2020
Primary completion27 December 2020
Estimated completion27 December 2020
Sites1 location across China

Drugs / interventions tested

Conditions studied

Sponsor

Peking University Third Hospital

Who can join

Adults 18 to 60, any sex, with Pigmented Villonodular Synovitis. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This study retrospectively analyzed the history of present illness of PVNS patients in our hospital. The enrolled patients were followed up by telephone to follow up their postoperative recovery and living conditions. Take the patient's pathological specimens for immunohistochemical testing, evaluate the relationship between the expression of different molecular targets, clinical manifestations and patient prognosis, and explore new molecular targets related to disease diagnosis and treatment.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other Peking University Third Hospital trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04955535.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing